ArticlePharmaceuticals (Basel, Switzerland)2021

Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer.

Hyo Jeong Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.